跳至主要内容
临床试验/ITMCTR2200006003
ITMCTR2200006003招募中未知

Survival Analysis after Hepatectomy for Hepatocellular Carcinoma: A Retrospective Cohort Study

Zhongshan Hospital Affiliated to Fudan University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 90(—)
性别
All

入选标准

  • ? It meets the diagnostic criteria of HCC and the characteristics of TCM syndrome differentiation and treatment; ? The general health status (PS) score is 0-2; ? Child Pugh is classified as a or B; ? The clinical stages of liver cancer in China (CNLC) are stage IA, stage IB, stage IIA and stage IIB; ? Radical treatment (Hepatectomy) after diagnosis of HCC is treatment measures and entered between December 2014 and may 2015; ? Postoperative TCM treatment mainly takes traditional Chinese medicine decoction (or granule); ? Postoperative medical treatment mainly included general medical treatment, transcatheter hepatic arterial chemoembolization (TACE) and systematic treatment; ? The original case data are relatively complete.

排除标准

  • ? Those who do not have the conditions for radical treatment; ? Patients with serious adverse reactions after traditional Chinese medicine and traditional Chinese medicine treatment; ? Patients with invasion or extrahepatic metastasis; ? Severe basic liver disease or combined with other serious basic diseases (including other malignant tumors); ? Serious lack of original case data.

研究者

发起方
Zhongshan Hospital Affiliated to Fudan University

相似试验